Tasedan - Pharmacology: Potentiates action of GABA, an inhibitory neurotransmitter, resulting in increased neuronal inhibition and CNS depression, especially in limbic system and reticular formation.
Indication: Short-term management of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings.
Tasedan is in a group of drugs called benzodiazepines (ben-zoe-dye-AZE-eh-peens). Tasedan affects chemicals in the brain that may become unbalanced and cause sleep problems (insomnia).
Tasedan is used to treat insomnia symptoms, such as trouble falling or staying asleep.
Tasedan may also be used for purposes other than those listed in this medication guide.
Tasedan, a triazolobenzodiazepine derivative, is an oral hypnotic agent with anticonvulsant, hypnotic, and muscle relaxant properties. It has been shown in some cases to be more potent than diazepam or nitrazepam.
Adult: 1-2 mg at night.
Elderly: Small or debilitated patients: Initially, 0.5 mg. Special Populations: Dose adjustments in renal impairment and liver disease.